Two Sigma Advisers
RXST icon

Two Sigma Advisers’s RxSight RXST Stock Holding History

Two Sigma Advisers’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-732,100
Closed -$7.63M – 1739
2025
Q4 		$7.63M Buy
732,100
+1,900
+0.3% +$19.1K 0.01% 640
2025
Q3 		$6.56M Buy
730,200
+548,800
+303% +$4.82M 0.01% 643
2025
Q2 		$2.36M Buy
181,400
+86,900
+92% +$1.31M ﹤0.01% 1036
2025
Q1 		$2.39M Sell
94,500
-37,500
-28% -$1.11M 0.01% 1087
2024
Q4 		$4.54M Sell
132,000
-74,800
-36% -$3.37M 0.01% 753
2024
Q3 		$10.2M Sell
206,800
-119,200
-37% -$6.11M 0.02% 483
2024
Q2 		$19.6M Sell
326,000
-38,400
-11% -$2.19M 0.04% 341
2024
Q1 		$18.8M Buy
364,400
+58,700
+19% +$2.88M 0.04% 362
2023
Q4 		$12.3M Buy
305,700
+35,400
+13% +$1.04M 0.03% 455
2023
Q3 		$7.54M Buy
270,300
+156,200
+137% +$4.66M 0.02% 573
2023
Q2 		$3.29M Buy
+114,100
New +$2.54M 0.01% 953

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Two Sigma Advisers's RXST Position: Q1 2026 in Review

Two Sigma Advisers sold out of RxSight (RXST) in Q1 2026, closing a stake of 732,100 shares — an estimated $7.63M sold.

Two Sigma Advisers first reported a position in RXST in Q2 2023 and held it in 11 quarters. The position peaked at $19.6M in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Two Sigma Advisers reported no remaining RxSight position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 732,100 RxSight shares in Q1 2026, an estimated $7.63M.
  • Two Sigma Advisers first reported a position in RxSight in Q2 2023 and held it in 11 quarters.
  • Two Sigma Advisers's RxSight position peaked at $19.6M in Q2 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.